Mostrando 10 resultados de: 22
Subtipo de publicación
Article(22)
Publisher
New England Journal of Medicine(5)
The Lancet(5)
American Heart Journal(3)
Diabetes Care(3)
Diabetes, Obesity and Metabolism(1)
Área temáticas
Enfermedades(15)
Fisiología humana(10)
Medicina y salud(7)
Problemas sociales y servicios a grupos(6)
Salud y seguridad personal(6)
Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)
ArticleAbstract: Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which mayPalabras claves:Apolipoproteins, Case-control, dyslipidemia, Lipoproteins, risk factor, strokeAutores:Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.L., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Hussain F.A., Iqbal R., Iversen H.K., Judge C., Lanas F., Langhorne P., Lisheng L., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’donnell M.J., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Sniderman A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.Fuentes:googlescopusAssociation of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study
ArticleAbstract: Background The relation between dietary nutrients and cardiovascular disease risk markers in many rePalabras claves:Autores:Agapay D., Aliberti A., Anand S.S., Aoucheva N., Arshad A., Avezum A.J., Azad A.K., Bangdiwala S.I., Casaccia G., Casanova A., Chen H., Cherry H.M., Chifamba J., Chin S.L., Chow C.K., Cuneo J.M., Dagenais G.R., Dehghan M., Devanath A., DIaz R., Dyal L., Elsheikh W., Gupta R., Hall K., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Iqbal R., Islam S., Iyengar Y., Joseph P.G., Kandy N., Kay I., Keneth J., Keys J., Khatib R., Kumar R., Kutty R., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Li W., Lindeman J., Linetsky B., Mackie P., Mannan A., McAlpine G., McQueen M.J., Mente A., Merchant A., Milazzo E., Mohammadifard N., Mohan V., Mushtaha M., Nasir N.M., Noorhassim I., Oguz A., Orlandini A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Puoane T., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Riggi M., Rimac J., Rosengren A., Seron P., Shahrook S., Shifaly F., Smyth A., Solano R., Swallow J., Swaminathan S., Teo K.K., Tongana T., Toscanelli S., Trottier M., Trottier S., Wang X., Wang Y., Wentzel-Viljoen E., Wielgosz A., Wong G.W.K., Yi S., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zatońska K., Zhang B., Zhang M.Fuentes:googlescopusAssociation of urinary sodium and potassium excretion with blood pressure
ArticleAbstract: BACKGROUND: Higher levels of sodium intake are reported to be associated with higher blood pressure.Palabras claves:Autores:Avezum A.J., Chifamba J., Devanath A., Di C., DIaz R., Iqbal R., Kelishadi R., Khatib R., Lanas F., Li W., McQueen M.J., Mente A., Mony P.K., Morrison H., Noorhassim I., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Poirier P., Puoane T., Rangarajan S., Rosengren A., Teo K.K., Wang X., Wielgosz A., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAvailability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
ArticleAbstract: Background Hypertension is considered the most important risk factor for cardiovascular diseases, buPalabras claves:Autores:Agapay D., Alhabib K.F., Aliberti A., Aoucheva N., Attaei M.W., Auger D., Avezum A.J., Azad A.K., Bahonar A., Casaccia G., Casanova A., Cherry H.M., Chin S.L., Choudhury T., Chow C.K., Dagenais G.R., Dayal L., Dehghan M., Dejesus J., Devanath A., DIaz R., Elsheikh W., Gupta R., Hall K., Haque R., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Igumbor E.U., Islam S., Joseph P.G., Kandy N., Kaur M., Kay I., Keneth J., Keys J., Khan M.U., Khatib R., Kruger L., Kutty R., Lanas F.T., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Lindeman J., Linetsky B., Mackie P., Maini Cuneo J.M., Mannan A., Marcilio C.S., Mattos A.C., Mckee M., McQueen M.J., Mente A., Milazzo E., Mohan V., Mushtaha M., Oguz A., Oliveira G.B.F., Orlandini A., O’Donnell M., Parvin S., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Rimac J., Rosengren A., Shahrook S., Shifaly F., Sintaha M., Smyth A., Solano R., Swallow J., Szuba A., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier M., Trottier S., Turbide G., Wang X., Wong G.W.K., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zhang B., Zhang M.Fuentes:googlescopusBasal insulin and cardiovascular and other outcomes in dysglycemia
ArticleAbstract: Background: The provision of sufficient basal insulin to normalize fasting plasma glucose levels mayPalabras claves:Autores:Abdallah A., Ahmad S., AHUAD GUERRERO R.A., Alebuena A., Alvarez N., Alzogaray M., Amuchastegui M., Andres M., Angos M., Avezum A.J., Baglivo H., Bahit M.C., Barbieri M., Bassi F., Bello F., Birkeland K.I., Bogaty P.M., Bono J., Bordeleau L., Bosch J.J., Budaj A.J., Bustamante Labarta M., Bustos B., Cardona E., Chacόn C., Chandra J., Chandra R., Chazova I.E., Commerford P.J., Corson M., Cukierman-Yaffee T., Dagenais G.R., Danilova L., Davies M., Díaz R., Dyal L., Fernando R., Fodor G.J., Gerstein H.C., Gilbert R., Gomis R., Halon D., Hâncu N., Hanefeld M., Harper W.L., Hildebrandt P., Johnston P., Joldersma L., Jung H., Kacerovsky-Bielesz G., Keltai M., Kim J.H., Krum H., Kultursay H., Lanas F.T., Lewis B.S., Lonn E.M., MacRae L., MacRae S., Maggioni A.P., Magloire P., Malik S., Mann J.F.E., Marin-Neto J.A., Marre M., McKelvie R., McQueen M.J., Mead A., Mendoza I., Morillo C.A., Pan C., Pasha F., PATRICIO LOPEZ -JARAMILLO, Pavlova V., Pazmino-Canizares J., Pirags V., Pogue J., Pohl K., Probstfield J.L., Profozic V., Punthakee Z., Ramachandran A., Ratner R., Richardson L., Riddle M.C., Rosenstock J., Rydén L.E., Sakalas A., Silva J., Spinas G.A., Sreenan S., Stoel I., Syvänne M., Tsang B., Tyrwhitt J., Vige R., Yakubovich N., Yale J.F., Yusuf S.Fuentes:scopusCardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)
ArticleAbstract: OBJECTIVE: The Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial reported neutralPalabras claves:Autores:Abdallah A., Ahmad S., AHUAD GUERRERO R.A., Alebuena A., Alvarez N., Alzogaray M., Amuchastegui M., Andres M., Angos M., Avezum A.J., Baglivo H., Bahit M.C., Barbieri M., Bassi F., Bello F., Birkeland K.I., Bogaty P.M., Bono J., Bordeleau L., Bosch J.J., Budaj A.J., Bustamante Labarta M., Bustos B., Cardona E., Chacόn C., Chandra J., Chandra R., Chazova I.E., Commerford P.J., Corson M., Cukierman-Yaffee T., Dagenais G.R., Danilova L., Davies M., DIaz R., Dyal L., Fernando R., Fodor G.J., Gerstein H.C., Gilbert R., Gomis R., Halon D., Hâncu N., Hanefeld M., Harper W.L., Hildebrandt P., Johnston P., Joldersma L., Jung H., Kacerovsky-Bielesz G., Keltai M., Kim J.H., Krum H., Kultursay H., Lanas F., Lewis B.S., Lonn E.M., MacRae L., MacRae S., Maggioni A.P., Magloire P., Malik S., Mann J.F.E., Marin-Neto J.A., Marre M., McKelvie R., McQueen M.J., Mead A., Mendoza I., Morillo C.A., Pan C., Pasha F., PATRICIO LOPEZ -JARAMILLO, Pavlova V., Pazmino-Canizares J., Pirags V., Pogue J., Pohl K., Probstfield J.L., Profozic V., Punthakee Z., Ramachandran A., Ratner R., Richardson L., Riddle M.C., Rosenstock J., Rydén L.E., Sakalas A., Silva J., Spinas G.A., Sreenan S., Stoel I., Syvänne M., Tsang B., Tyrwhitt J., Vige R., Yakubovich N., Yale J.F., Yusuf S.Fuentes:scopusCardiovascular risk and events in 17 low-, middle-, and high-income countries
ArticleAbstract: BACKGROUND: More than 80% of deaths from cardiovascular disease are estimated to occur in low-incomePalabras claves:Autores:Anand S.S., Avezum A.J., Bo J., Chifamba J., Dagenais G.R., DIaz R., Gupta R., Iqbal R., Islam S., Kelishadi R., Kruger A., Kumar R., Lanas F., Lear S.A., Li W., Liu L., Liu T., Lou Q., Lu F., Mckee M., McQueen M.J., Mohan V., Mony P.K., Noorhassim I., Oguz A., PATRICIO LOPEZ -JARAMILLO, Puoane T., Rahman O., Rangarajan S., Rosengren A., Swaminathan S., Szuba A., Teo K.K., Vijayakumar K., Wielgosz A., Yu L., Yusoff K., Yusuf S., Yusufali A.M., Zhang S.Fuentes:googlescopusGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
ArticleAbstract: Background Stroke is a leading cause of death and disability, especially in low-income and middle-inPalabras claves:Autores:Agapay S., Al Hussain F., Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., Dehghan M., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Iqbal R., Iversen H.K., Lanas F., Langhorne P., Liu L., Magazi D., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H., Zhang X.Fuentes:googlescopusEffect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: The glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)
ArticleAbstract: OBJECTIVE-To evaluate the effects of insulin glargine and n-3 polyunsaturated fatty acid (n- 3FA) suPalabras claves:Autores:Bosch J.J., DIaz R., Dyal L., Gerstein H.C., Hâncu N., Hanefeld M., Krum H., Lonn E.M., McQueen M.J., PATRICIO LOPEZ -JARAMILLO, Ramachandran A., Rydén L.E., Smith S., Yusuf S.Fuentes:googlescopus